Skip to main content
SpringerLink
Log in

Platelet Fc receptors for IgG and IgE

  • Chapter
The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity

Part of the book series: Immunology and Medicine Series ((IMME,volume 26))

  • 114 Accesses

Abstract

Platelets are a major source for human Fc receptors. Together with their precursors, the megakaryocytes, they express membrane bound Fc receptors and produce soluble Fc receptors. Receptors for IgG, the Fcγreceptor, and IgE, the Feεreceptor, are expressed at the platelet surface, respectively.

Literature up to November 1996 is included.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cassel DL, Keller MA, Surrey S et al. Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells:analysis of transcripts. Mol Immunol. 1993; 30: 451–60.

    Article  PubMed  CAS  Google Scholar 

  2. Gosselin EJ, Brown MF, Anderson CL, Zipf TF, Guyre PM. The monoclonal antibody 41H16 detects the Leu 4 responder form of human Fc gamma RII. J Immunol. 1990; 144 (5):1817–22.

    Google Scholar 

  3. Karas SP, Rosse WF, Kurlander RJ. Characterization of the IgG-Fc receptor on human platelets. Blood. 1982; 60: 1277–82.

    PubMed  CAS  Google Scholar 

  4. Rosenfeld SI, Anderson CL. Fc receptor of human platelets. In: Kunicki TJ, Georg JN, eds. Platelet Immunobiology, Molecular and Clinical Aspects. Lippincott Company: Philadelphia; 1989: 337–53.

    Google Scholar 

  5. King M, McDermott P, Schreiber AD. Characterization of the Fc gamma receptor on human platelets. Cell Immunol. 1990; 128(2):462–79.

    Article  PubMed  CAS  Google Scholar 

  6. Looney RJ, Anderson CL, Ryan DH, Rosenfeld SI. Structural polymorphism of the human platelet Fcγreceptor. J Immunol. 1988; 141: 2680–3.

    PubMed  CAS  Google Scholar 

  7. Rosenfeld SI, Ryan DH, Looney RI, Anderson CL, Abraham GN, Leddy JP. Human Fcγreceptor:stable inter-donor variation in quantitative expression on platelets correlates with functional responses. J Immunol. 1987; 138: 2869–73.

    PubMed  CAS  Google Scholar 

  8. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN. Increased expression of platelet IgG Fc receptors in immune-induced thrombocytopenia. Blood. 1993; 81: 988–93.

    PubMed  CAS  Google Scholar 

  9. Kiss C, Surrey S, Schreiber AD, Schwartz E, McKenzie SE. Human c-kit ligand (stem cell factor) induces platelet Fc receptor expression in megakaryoblastic cells. Exp Hematol. 1996; 24: 1232–7.

    PubMed  CAS  Google Scholar 

  10. Tate BJ, Witort E, McKenzie IFC, Hogarth PM. Expression of the high responder/non-responder human FcγRII. Analysis by PCR and transaction into FcR-COS cells. Immunol Cell Biol. 1992; 70: 79–87.

    Article  PubMed  CAS  Google Scholar 

  11. Warmerdam PAM, van de Winkel JGJ, Vlug A, Westerdaal NAC, Capel PJA. A single amino acid in the second Ig-like domain of the human Fcγreceptor II is critical for human IgG2 binding. J Immunol. 1991; 147: 1338–43.

    PubMed  CAS  Google Scholar 

  12. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood. 1992; 80: 2261–8.

    PubMed  CAS  Google Scholar 

  13. McCrae KR, Shattil SJ, Cines DB. Platelet activation induces increased Fc gamma receptor expression. J Immunol. 1990; 144: 3920–7.

    PubMed  CAS  Google Scholar 

  14. Rappaport EF, Cassel DL, Walterhouse DO et al. A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection. Exp Hematol. 1993; 21: 689–96.

    PubMed  CAS  Google Scholar 

  15. Markovic B, Wu Z, Chesterman CN, Chong BH. Quantitation of soluble and membrane-bound Fc gamma RUA (CD32A) mRNA in platelets and megakaryoblastic cell line (Meg-01). Br J Haematol. 1995; 91: 37–42.

    Article  PubMed  CAS  Google Scholar 

  16. Gachet C, Astier A, de la Salle H et al. Release of Fc gamma RIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant Fc gamma RIIa2. Blood. 1995; 85: 698–704.

    PubMed  CAS  Google Scholar 

  17. Anderson CL, Chacko GW, Osborne JM, Brandt JT. The Fc receptor for immunoglogulin G (FcγRII) on Human platelets. Semin Thromb Hemost. 1995; 21:l-9.

    Google Scholar 

  18. Horton MA, Hogg N. Platelet antigens: new and previously defined clusters. In: McMichael AJ, ed., Leucocyte Typing III. White Cell Differentiation Antigens. Oxford: University Press Oxford; 1987: 733–46.

    Google Scholar 

  19. von dem Borne AEGK, Modderman PW, Admiraal LG, Nieuwenhuis HK. Joint report of the platelet section. Platelet antibodies, the overall results. In: Knapp W, ed., Leucocyte Typing IV. White Cell Differentiation Antigens. Oxford: University Press Oxford; 1989: 951–66.

    Google Scholar 

  20. Griffith L, Slupsky J, Seehafer J, Boshkov L, Shaw AR. Platelet activation by immobilized monoclonal antibody:evidence for a CD9 proximal signal. Blood. 1991; 78(7): 1753–9.

    PubMed  CAS  Google Scholar 

  21. Carroll RC, Rubinstein E, Worthington RE, Boucheix C. Extensive Clq-complement initiated lysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen. Thromb Res. 1990; 59: 831–9.

    Article  PubMed  CAS  Google Scholar 

  22. De Reys S, Blom C, Lepoudre B et al. Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent. Blood. 1993; 81: 1792–800.

    PubMed  Google Scholar 

  23. Nomura S, Yamaguchi K, Kido H et al. New monoclonal anti-human Fc gamma receptor II antibodies induce platelet aggregation. Clin Exp Immunol. 1991; 86: 179–84.

    Article  PubMed  CAS  Google Scholar 

  24. Gulino D, Ryckewaert JJ, Andrieux A, Rabiet MJ, Marguerie G. Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-binding site and induces aggregation. J Biol Chem. 1990; 265: 9575–81.

    PubMed  CAS  Google Scholar 

  25. Kouns WC, Jennings LK. Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor. Thromb Res. 1991; 63: 343–54.

    Article  PubMed  CAS  Google Scholar 

  26. Rubinstein E, Kouns WC, Jennings LK, Boucheix C, Carroll RC. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII). Br J Haematol. 1991; 78: 80–6.

    Article  PubMed  CAS  Google Scholar 

  27. Frelinger AL, Du X, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein lib-Ilia) alter receptor affinity, specificity, and function. J Biol Chem. 1991; 266: 17106–11.

    PubMed  CAS  Google Scholar 

  28. Osborne JM, Brandt JT, Chacko GW, Anderson CL. CD 32 dependence of antibody-mediated platelet aggregation. In: Schlossmann SF, Boumsell L, Wally Gilks et al., eds, Leucocyte Typing V. White Cell Differentiation Antigens. Oxford: University Press Oxford; 1993: 1251–5.

    Google Scholar 

  29. Rubinstein E, Boucheix C, Worthington RE, Carroll RC. Anti-platelet antibody interactions with Fcγreceptor. Semin Thromb Haemost. 1995;21: 10–22.

    Google Scholar 

  30. Slupsky JR, Seehafer JG, Tang SC, Masellis-Smith A, Shaw AR. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem. 1989; 264: 12289–93.

    PubMed  CAS  Google Scholar 

  31. Horsewood P, Hayward CP, Warkentin TE, Kelton JG. Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood. 1991; 78: 1019–26.

    PubMed  CAS  Google Scholar 

  32. Rubinstein E, Urso I, Boucheix C, Carroll RC. Platelet activation by cross-linking HLA class I molecules and Fc receptor. Blood. 1992; 79: 2901–8.

    PubMed  CAS  Google Scholar 

  33. Anderson GP, Anderson CL Signal transduction by the platelet Fc receptor. Blood. 1990; 76(6): 1165–72.

    PubMed  CAS  Google Scholar 

  34. Anderson GP, van de Winkel JG, Anderson CL. Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction. Br J Haematol. 1991; 79: 75–8.

    Article  PubMed  CAS  Google Scholar 

  35. Rubinstein E, Boucheix C, Urso I, Carroll RC. Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin. J Immunol. 1991; 147: 3040–6.

    PubMed  CAS  Google Scholar 

  36. Slupsky JR, Cawley JC, Griffith LS, Shaw ARE, Zuzel M. Role of FcγRII in platelet activation by monoclonal antibodies. J Biol Chem. 1992; 148: 3148–94.

    Google Scholar 

  37. Bachelot C, Saffroy R, Gandrille S, Aiach M, Rendu F. Role of FcγRIIa gene polymorphism in human platelet activation by monoclonal antibodies. Thromb Haemost. 1995; 74: 1557–63.

    PubMed  CAS  Google Scholar 

  38. Parren PW, Warmerdam PA, Boeije LC et al. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin Invest. 1992; 90: 1537–46.

    Article  PubMed  CAS  Google Scholar 

  39. Roberts JJ, Rodgers SE, Drury J, Ashman LK, Lloyd JV. Platelet activation induced by a murine monoclonal antibody directed against a novel tetra-span antigen. Br J Haematol. 1995; 89: 853–60.

    Article  PubMed  CAS  Google Scholar 

  40. Burgess JK, Lindeman R, Chesterman CN, Chong BH. Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol. 1995; 91: 761–6.

    Article  PubMed  CAS  Google Scholar 

  41. Lecompte T, Stieltjes N, Shao-Kai L, Morel MC, Kaplan C, Meyer Samama M. Heparin-and streptokinase-dependent platelet-activating immunoglobulin G: mechanism and diagnosis. Semin Thromb Haemost 1995; 21: 95–105.

    Article  CAS  Google Scholar 

  42. Kang J, Cabrai C, Kushner L, Salzman EW. Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation. Blood. 1993; 81: 1505–12.

    PubMed  CAS  Google Scholar 

  43. Adelmann B, Sobel M, Fujimura Y, Ruggieri ZM, Zimmerman TS. Heparin-associated thrombocytopenia: observations on the mechanism of platelet aggregation. J Lab Clin Med. 1989; 113: 204–10.

    Google Scholar 

  44. Kelton JG, Sheridan D, Santos A et al. Heparin-induced thrombocytopenia. Blood. 1988; 72: 925–30.

    PubMed  CAS  Google Scholar 

  45. Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation a possible new indication for high dose i.v. IgG. Thromb Haemost. 1994; 71: 641–5.

    PubMed  CAS  Google Scholar 

  46. Haimovich B, Regan C, DiFazio L et al. FcγRII receptor triggers pp 125FAK phosphorylation in platelets. Biol Chem. 1996; 271: 16332–37.

    Article  CAS  Google Scholar 

  47. Gibbins J, Asselin J, Farnadals R, Barnes M, Law C-L, Watson SP. Tyrosine phosphorylation of the Fc receptor y-chain in collagen-stimulated platelets. J Biol Chem. 1996; 271: 18095–9.

    Article  PubMed  CAS  Google Scholar 

  48. Kelton JG, Horsewood P. Antibody-mediated platelet activation. J Lab Clin Med. 1993; 121: 382–4.

    PubMed  CAS  Google Scholar 

  49. Mueller Eckhardt C, Lüscher EF. Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatelet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin. Thromb Diath Haemorrh. 1968; 20: 155–67.

    PubMed  CAS  Google Scholar 

  50. Schattner M, Lazzari M, Trevani AS et al. Activation of human platelets by immune complexes prepared with cationized human IgG. Blood. 1993; 82: 3045–51.

    PubMed  CAS  Google Scholar 

  51. Kuroda K, Ozaki Y, Qi R et al. FcγII receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ Channels which are distinct from those associated with Ca2+ store depletion. J Immunol. 1995; 155: 4427–36.

    PubMed  CAS  Google Scholar 

  52. Blake RA, Asselin J, Walker T, Watson SP. Fc gamma receptor II stimulated formation of inositol phosphates in human platelets is blocked by tyrosine kinase inhibitors and associated with tyrosine phosphorylation of the receptor. FEBS Lett. 1994; 342: 15–8.

    Article  PubMed  CAS  Google Scholar 

  53. Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS. Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII. J Biol Chem. 1992; 267: 5467–73.

    PubMed  CAS  Google Scholar 

  54. Blake RA, Schieven GL, Watson SP. Collagen stimulates tyrosine phosphorylation of phospholipase C-gamma 2 but not phospholipase C-gamma 1 in human platelets. FEBS Lett. 1994; 353: 212–6.

    Article  PubMed  CAS  Google Scholar 

  55. Chacko GW, Duchemin AM, Coggeshall KM, Osborne JM, Brandt JT, Anderson CL. Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72syk. J Biol Chem. 1994; 269: 32435–40.

    PubMed  CAS  Google Scholar 

  56. Chacko GW, Brandt JT, Coggeshall KM, Anderson CL. Phosphoinositide 3-kinase and p72syk noncovalently associate with the low affinity Fc gamma receptor on human platelets through an immunoreceptor tyrosine-based activation motif. Reconstitution with synthetic phosphopeptides. J Biol Chem. 1996; 271: 10775–81.

    Article  PubMed  CAS  Google Scholar 

  57. Yanaga F, Poole A, Asselin J et al. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor. Biochem J. 1995; 311: 471–8.

    PubMed  CAS  Google Scholar 

  58. Robinson A, Gibbins J, Rodriguez-Linares B et al. Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking. Blood. 1996; 88: 522–30.

    PubMed  CAS  Google Scholar 

  59. Heinrich D, Stephinger U, Mueller-Eckhardt Ch. Specific interaction of HLA antibodies (eluates) with washed platelets. Br J Haematol. 1977; 35: 441–52.

    Article  PubMed  CAS  Google Scholar 

  60. Rubinstein E, Urso I, Boucheix C, Carroll RC. Platelet activation by cross-linking HLA class I molecules and Fc receptor. Blood. 1992; 79: 2901–8.

    PubMed  CAS  Google Scholar 

  61. Christie DJ, Leja DN, Carlson DL, Swinehart CD. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia [published erratum appears in J Lab Clin Med. 1993; 122: 227] J Lab Clin Med. 1993; 121: 437-43.

    Google Scholar 

  62. Brandt JT, Julius CJ, Osborne JM, Anderson CL. The mechanism of platelet aggregation induced by HLA-related antibodies. Thromb Haemost. 1996; 76: 774–9.

    PubMed  CAS  Google Scholar 

  63. Yanabu M, Nomura S, Fukuroi T et al. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura. Br J Haematol. 1993; 84(4):694–701.

    Article  PubMed  CAS  Google Scholar 

  64. Babcock RB, Dumper CW, Scharfman WB. Heparin-induced immune thrombocytopenia. N Engl J Med. 1976; 295: 237–41.

    Article  PubMed  CAS  Google Scholar 

  65. Chong BH, Pitney WR, Castaldi PA. Heparin-induced thrombocytopenia.association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet. 1982;2: 1246–9.

    Google Scholar 

  66. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986; 67: 27–30.

    PubMed  CAS  Google Scholar 

  67. Warkentin TE, Hayward CPM, Smith CA, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med. 1992;120: 371–9.

    Google Scholar 

  68. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost. 1991;66: 734–6.

    Google Scholar 

  69. Greinacher A. Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost. 1995; 21: 106–16.

    Article  PubMed  CAS  Google Scholar 

  70. Greinacher A, Michels I, Liebenhoff U, Presek P, Mueller-Eckhardt C. Heparin-associated thrombocytopenia:immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. Br J Haematol. 1993; 84: 711–6.

    Article  PubMed  CAS  Google Scholar 

  71. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia (letter). Thromb Hemost. 1992; 68–95-6.

    Google Scholar 

  72. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994; 93: 81–8.

    Article  PubMed  CAS  Google Scholar 

  73. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Hordewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood. 1994; 83: 3232–9.

    PubMed  CAS  Google Scholar 

  74. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia.isolation of the antibody and characterization of a multi-molecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994; 71: 247–51.

    PubMed  CAS  Google Scholar 

  75. Amiral J, Bridey F, Wolf M et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost. 1995; 73: 21–8.

    PubMed  CAS  Google Scholar 

  76. Chong BH, Fawaz I, Chesterman CN, Berndt MC. Heparin-induced thrombocytopenia:me-chanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol. 1989; 73: 235–40.

    Article  PubMed  CAS  Google Scholar 

  77. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood. 1994; 83: 1535–41.

    PubMed  CAS  Google Scholar 

  78. Aster RH. Heparin-induced thrombocytopenia and thrombosis [editorial;comments]. N Engl J Med. 1995; 332: 1374–6.

    Article  PubMed  CAS  Google Scholar 

  79. Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckhardt C. Characterization of the strucural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immonological type of heparin-associated thrombocytopenia. Thromb Haemost. 1995; 74: 886–92.

    PubMed  CAS  Google Scholar 

  80. Warkentin TE. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transf Med Rev. 1996; 10: 249–58.

    Article  CAS  Google Scholar 

  81. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987; 316: 581–9.

    Article  PubMed  CAS  Google Scholar 

  82. Arepally, G. Poncz M, McKenzie SE, Cines D. Characterization of antibody subclass specificity and antigenic determinants in heparin-associated thrombocytopenia. Blood. 1994; 84:Abstract 740.

    Google Scholar 

  83. Brandt JT, Isenhart CE, Osborne JM, Ahmed A, Anderson CL. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost. 1995; 74: 1564–72.

    PubMed  CAS  Google Scholar 

  84. Warkentin TE, Sheppard JI, Denomme GA, Kelton JG. FcγIIa receptor genotype hetero-genieity and platelet activation by heparin-induced thrombocytopenia IgG (HIT-IgG): A possible explanation for the predominance of the ‘low responder’ (His) FcγIIa receptor genotype in HIT patients. Blood. 1995; 86(Suppl l):537a.

    Google Scholar 

  85. Greinacher A, Baurichter G, Olbrich K et al. Association of human platelet FcγRIIa (CD32) genotype with heparin-induced thrombocytopenia (HIT). Ann Hematol. 1996; 72: 349.

    Google Scholar 

  86. Arepally G, McKenzie SE, Poncz M, Cines DB. FcγRIIa polymorphism, subclass-specific IgG anti-heparin/PF4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood. 1996; 88(1):Abstract 1111.

    Google Scholar 

  87. Lebrazi J, Helft G, Abdelouahed M et al. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner. Thromb Haemost. 1995; 74: 938–42.

    PubMed  CAS  Google Scholar 

  88. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other ‘antiphospholipid’autoantibodies. Blood. 1994; 84: 2854–67.

    PubMed  CAS  Google Scholar 

  89. Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol. 1996; 93: 1–5.

    Article  PubMed  CAS  Google Scholar 

  90. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost. 1996; 75: 536–41.

    PubMed  CAS  Google Scholar 

  91. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990; 335: 1544–7.

    Article  PubMed  CAS  Google Scholar 

  92. Arvieux J, Roussel B, Pouzol P, Colomb MG. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I. Thromb Haemost. 1993; 70: 336–41.

    PubMed  CAS  Google Scholar 

  93. Shi W, Chong BH, Chesterman CN. Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets:differences with lupus anticoagulants. Blood. 1993; 81: 1255–62.

    PubMed  CAS  Google Scholar 

  94. Frame JN, Mulvey KP, Phares JC, Anderson MJ. Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin. Am Intern Med. 1989; 111: 946–7.

    CAS  Google Scholar 

  95. Grau E, Linares M, Olaso A, Ruvira J, Sauchris J. Heparin-induced thrombocytopenia-response to intravenous immunoglobulins in vivo and in vitro. Am J Hematol. 1992; 39: 312–3.

    Article  PubMed  CAS  Google Scholar 

  96. Dessaint JP, Tsicopoulos A, Pancré V et al. Platelets, IgE and allergy. In: Kaplan-Gouet C, Schlegel N, Salomon C, McGregor J, eds, Platelet Immunology: Fundamental and Clinical Aspects. Colloque INSERM: John Libbey Eurotext Ltd. 1991; 206: 187–94.

    Google Scholar 

  97. Joseph M, Capron A, Ameisen JC et al. The receptor for IgE on blood platelets. Eur J Immunol. 1986; 16: 306–12.

    Article  PubMed  CAS  Google Scholar 

  98. Cines DB, van der Keyl H, Levinson AI. In vitro binding of an IgE protein to human platelets. J Immunol. 1986; 136: 3433–40.

    PubMed  CAS  Google Scholar 

  99. Pancré V, Joseph M, Capron A et al. Recombinant human immune interferon induces increased IgE receptor expression on human platelets. Eur J Immunol. 1988; 18: 829–32.

    Article  PubMed  Google Scholar 

  100. Ameisen JC, Joseph M, Cean JP et al. A role for glycoprotein IIb-IIIa complexe in the binding of IgE to human platelets and platelet IgE-dependent cytotoxic functions. Br J Haematol. 1986; 64: 21–32.

    Article  PubMed  CAS  Google Scholar 

  101. Joseph M, Auriault C, Capron A, Vorng H, Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 1983; 303: 810–2.

    Article  PubMed  CAS  Google Scholar 

  102. Haque A, Cuna W, Bonnel B, Capron A, Joseph M. Platelet-mediated killing of larvae from different filarial species in the presence of Dipetalonema viteae stimulated IgE antibodies. Parasite Immunol. 1985; 7: 517–26.

    Article  PubMed  CAS  Google Scholar 

  103. Capron A, Dessaint JP. Immunologic aspects of schistosomiasis. Ann Rev Med. 1992; 43: 209–18.

    Article  PubMed  CAS  Google Scholar 

  104. Cesborn JY, Capron A, Vargaftig BB et al. Platelets mediate the action of diethylcarbamazine on microfilariae. Nature. 1987; 325: 533–6.

    Article  Google Scholar 

  105. Vanhee D, Joseph M, Vorng H, Tonnel AB. A colorimetric assay to evaluate the immune reactivity of blood platelets based on the reduction of a tetrazolium salt. J Immunol Meth. 1993; 159: 253–9.

    Article  CAS  Google Scholar 

  106. Masini E, Di-Bello MG, Raspanti S, Sacchi TB, Maggi E, Mannaione PF. Platelet aggregation and histamine release by immunological stimuli. Immunopharmacology. 1994; 28: 19–29.

    Article  PubMed  CAS  Google Scholar 

  107. Cardot E, Pestel J, Callebaut I et al. Specific activation of platelets from patients allergic to dermatophagoides pteronyssinus by synthetic peptides derived from the allergen Der p I. Int Arch Allergy Immunol. 1992; 98: 127–34.

    Article  PubMed  CAS  Google Scholar 

  108. Jeannin P, Pestel J, Bossus M, Lassalle P, Tartar A, Tonnel AB. Comparative analysis of biological activities of Der p I-derived peptides on Fc epsilon receptor-bearing cells form Dermatophagoides pteronyssinus-sensitive patients. Clin Exp Immunol. 1993; 92: 133–8.

    Article  PubMed  CAS  Google Scholar 

  109. Tsicopoulos A, Tonnel AB, Wallaert B et al. Decrease of IgE-dependent platelet activation in Hymenoptera hypersensitivity after specific rush desensitization. Clin Exp Immunol. 1988; 71: 433–8.

    PubMed  CAS  Google Scholar 

  110. Rogala B, Gumprecht J, Gawlik R, Strojek K. Platelet aggregation in IgE-mediated allergy with elevated soluble Fc epsilon RII/CD23 level. J Investig Allergol Clin Immunol. 1995; 5: 161–6.

    PubMed  CAS  Google Scholar 

  111. Askenase PW, Geba GP, Levin J et al. A role for platelet release of serotonin in the initiation of contact sensitivity. Int Arch Allergy Immunol. 1995; 107: 145–7.

    Article  PubMed  CAS  Google Scholar 

  112. Bermejo N, Gueant JL, Bata E, Gerard P, Moneret-Vautrin DA, Laxenaire MC. Platelet serotonin is a mediator potentially involved in anaphylactic reaction to neuromuscular blocking drugs. Br J Anaesth. 1993; 70: 322–5.

    Article  PubMed  CAS  Google Scholar 

  113. Tunon de Lara JM, Rio P, Marthan R, Vuillemin L, Ducassou D, Taytard A. The effect of sodium cromoglycate on platelets:an in vivo and in vitro approach. J Allergy Clin Immunol. 1992; 89: 994–1000.

    Article  Google Scholar 

  114. Rio P, Tunon de Lara JM, Marthan R, Taytard A. IgE binding inhibits arachidonic acid-induced chemiluminescence of human platelets. Clin Exp Allergy. 1992; 22: 91–7.

    Article  PubMed  CAS  Google Scholar 

  115. Wilhelm D, Kluter H, Kloche M, Kirchner H. Impact of allergy screening for blood donors: relationship to nonhemolytic transfusion reactions. Vox Sang. 1995; 69: 217–21.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Greinacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Utrecht University, Utrecht, The Netherlands

    Jan G. J. van de Winkel

  2. Austin Research Institute, Melbourne, Australia

    P. Mark Hogarth

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Greinacher, A. (1998). Platelet Fc receptors for IgG and IgE. In: van de Winkel, J.G.J., Hogarth, P.M. (eds) The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity. Immunology and Medicine Series, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5018-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5018-7_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6106-3

  • Online ISBN: 978-94-011-5018-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation